LDS/Medical Tests/Barbiturates, Confirmation, Urine

Barbiturates, Confirmation, Urine

Barbiturates are a class of drugs that are typically used by drug abusers. It belongs to a class of drugs derived from barbituric acid (malonylurea), which are known as sedatives and have hypnotic/depressant affects in the central nervous system (CNS). As CNS-depressants, the barbiturates are classified relative to their duration of action (ultra short-, short-, intermediate-, and long-acting). In medical practice, barbiturates are often used as sedatives to reduce emotional tension and induce sleep, and in certain types of epilepsy to reduce seizure frequency by raising the seizure threshold. Excessive dosages may cause impaired motor coordination (slurred speech, loss of balance), perceptual alterations (faulty judgment, inflated perceptions of performance), and disinhibition euphoria.

Overdoses can result in stupor, coma, and death. The combined use of the barbiturates with alcohol, opiates, or other CNS-depressants can result in fatal, additive respiratory depression.

The Urine Barbiturate test is designed to detect the presence of the class of drugs termed barbiturates in human urine as a qualitative or semi-quantitative screening test.

  • Therapeutic monitoring
  • Drug abuse evaluation
  • Toxicity assessment
A positive result from this test indicates only the presence of Barbiturates and does not necessarily correlate with the extent of physiological and psychological effects. Any positive result should be confirmed by a non-immunological method such as GC, TLC, or GC/MS.

Cutoff concentration
Immunoassay
< 200 ng/mL

Enzyme Immunoassay

Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Adulteration of the urine specimen can result in erroneous results.

Stability

  • Ambient: 5 days
  • Refrigeration: 7 days
Any Positive test result should be confirmed by GC, TLC, or GC/MS. Additional tests may include Diazepam, Ethanol, Methylphenobarbital, Liver Panel, Comprehensive Metabolic Panel, Drug of abuse screen.
Usually same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Addict Dis. 2010 Oct;29(4):436-48. [PMID: 20924879]
  • Clin Toxicol (Phila). 2011 Jan;49(1):2-12. [PMID: 21288146]
  • Ann Clin Biochem. 1997 Sep;34 ( Pt 5):460-510. [PMID: 9293303]
  • Urine Testing for Drug Abuse. National Institute on Drug Abuse (NIDA) Research Monograph. 73, 1986.